Home » Successful Interventions in Response to COVID-19

On 11 March, World Health Organization officially declared Coronavirus Disease 2019 (COVID-19) a pandemic. Since the outbreak began, as of 3 April, more than 1 million cases and over 58,000 deaths have been reported in 204 countries and territories. The impact of the current global pandemic is affecting every aspect of life from health, economies, and even basic social interactions. In response to this unprecendented global crisis, individuals and organizations are jumping into action individually and collectively and diaspora are not only often the first to respond, their political, social, cultural and human capital coupled with their knowledge of the country, local languages, as well as social, cultural, and religious norms, can lead to more targeted and tailor responses.

Through this forum we want to collect and  share experiences and best practices in terms of diaspora response to the COVID-19 pandemic as well as other similar emergency situations in the past. The purpose is twofold: first, to create a space for diaspora groups from different communities to share experiences and best practices in order to maximize their impact within their efforts to respond to the COVID-19 crisis and beyond, and secondly, to showcase and bring attention to the important work that diaspora groups are doing on the ground in order to encourage policy makers and practitioners to strengthen their collaboration and support to such efforts.

Your invited to share examples of your successful interventions as best practices and/or inspiration for others that are still exploring ways to contribute to addressing this global challenge.

Médias for Developpement during and after COVID 19

1. AFRICAPRESS EXPRESS AGENCY of RATV
Yaoundé, Dakar, Kinshasa, Lagos, Pretoria, Nairobi

The Medias play a very important role in raising awareness and transmitting information. As multipliers and opinion makers in times like these, the roles of the Medias become even more important. While many countries have already closed their land and air borders, only the media enjoy freedom of movement thanks to modern technology not only within the borders of countries but also beyond, even across the five continents of the world. As a result, people all over the world communicate and inform each other through the media on all sides.

The creation of the Express news agency is motivated by the consequences of the COVID-19 pandemic which, due to the speed of social media, the world is witnessing a flow of information. Indeed, the multitudes of social media have generated multiple information on the African continent disseminated around the world and especially here in Europe. Sometimes some of these social media corroborate false information. RATV, in its noble mission to present the true image of Africa, sees itself as having a duty to help anyone who wants to have access to a viable source of information, verified using journalistic methods. RATV's express news agencies will be able to produce or write radio and TV programmes as well as articles for the written press. RATV will not only be able to use them in its programmes but also to act as an agency for other media that need or request them or other users.
It is to be recommended to put emphasis on radio and television programmes, as these are only the monopoly of a few western countries, and they therefore have the privilege to serve as only one source of information and they lead it as they want.
Africans must produce and disseminate their own information themselves to the Western countries. The Initiatives such as this one by Radio Afrika Tv exist everywhere but suffer from a lack of financial Resources.
RATV's express news agency has been integrated into the regional offices in Africa since April 2020. It is made up of journalists from the regional offices. It consists in producing express and reliable news and journalistic productions. For the moment, these agencies are already established in Yaoundé, Dakar, Kinshasa, Lagos, Pretoria, and Nairobi and may be expanded to other African countries.

2. COVID-19 will be over soon, but the war against poverty have to go on!

Development programs need to be distinguished from simple advertising. In the foreground stand vital problem solutions that are made popular by the media. That gives the audience the opportunity to connect with those who offer solutions. Local, already existing entrepreneurs in Africa as well public decision-makers should look to the innovative ideas of this programs can be alerted and can communicate directly with those who have solutions to offer.

This and next year’s focus of Radio Africa TV is to promote sustainable development concepts. We are convinced that the economic development and the building up of social enterprises in Africa is a sustainable way to support the growth of African countries.
Instead of often misplaced development aid, the transfer of Technology and know-how supports a brain gain in African countries. Radio Africa TV contributes in its role as established and good networked medium to spread new technologies to a broad mass of consumers.

Many young Africans are dying on their way to exile. They flee from poverty and unemployment. However, there is no lack of ideas for solving this difficult situation, but the availability of programs between Business partners between Europe and Africa is marginal.
In order to promote economic development - in areas such as water supply, energy production, education, health etc. Radio Afrika TV works together with partners on a sustainable future for Africa.
The transfer of knowledge and/or technologies is the focus of the present Project. Life - enhancing technologies should help the African people to create new jobs, know-how and knowledge and to improve the health situation of vulnerable people to bring about sustainable, positive changes.
Central is the role of the African Diaspora, which is the bridge between Austria and African countries. As local experts in Africa Members of the diaspora not only identify the best-placed opportunities to invest or promote the campaign, but also maneuver skillfully regional obstacles that affect Austrians who work in Africa.
Targeted work with local media is an integral part of the project. The design of radio and TV programs as well as newspaper articles and magazines in Africa is helping the local population to overcome existing problems to inform solutions and promote concrete new technologies and to give them access to them. In Austria, media are used skillfully to the Austrian population to support a positive alternative to the repetitive negative pictures and stories about African countries and to focus on "sustainable job creation instead of flight".

The creation of Jobs for young entrepreneurs is crucial: The lack of Jobs and perspectives that put young Africans in the path of Exile and in mortal danger in the Mediterranean must be stopped at all costs. Instead of classic development aid sustainable solutions focus on the financial independence of African population.

network

SASTA has created a task force of scientists around the world to work on system change.  We are in the process of initation

Risk Assessment of COVID19

Risk Assessment of COVID19 using the BioAgent Transport and Environmental Modeling System (BioTEMS)

 

1. IDENTIFICATION AND SIGNIFICANCE OF THE PROBLEM

1.1 Executive Summary

The world faces an ever-growing threat from emerging pathogens and diseases, most recently Coronavirus disease 2019 (COVID19). In addition to clinical care, surveillance testing is a major factor in effective mitigation of infectious diseases. Surveillance includes identifying prevalence, incidence and identifying where COVID19 is found in populations in order to optimize testing and reduce the spread of COVID19. Emerging RT PCR kits and immunoassays are effective tools for identifying current and past COVID19 infections in clinical samples and can be used proactively to test sample populations. When testing kits are not available, interviews and surveys in communities can be used to ascertain potential exposure and infections in communities. Because it is not possible to test the entire population in large cities, the BioAgent Transport and Environmental Modeling System (BioTEMS) was developed to provide emergency response and public health personnel the information they need to enhance planning and target high risk areas in a cost and time-effective manner. Conducting surveillance by sampling at the community level optimizes available resources to combat the spread of disease. The BioTEMS COVID19 Risk Assessment Map (RAM) was developed for exactly this purpose.

 

Concerns for mitigation of COVID19 include; 1) Passively waiting for patients to be tested greatly underestimates the risk to the population, 2) Not testing for persistence and transmission SARS COV-2 in the environment in likely reservoirs underestimates the risk of re-emergence and genetic modification. The BioTEMS COVID19 RAM provides the public health administration an effective tool in answering these two questions rapidly and at greatly reduced cost.  For example, instead of testing 4,335 people in a community, 458 people can be tested at a 95% confidence level using the BioTEMS COVID19 RAM. Another very important factor for disease detection is sampling in the environment. The BioTEMS COVID19 RAM greatly reduces the area needed for accurate sampling. By accurately identifying Who and Where COVID19 sampling should be conducted, BioTEMS can save over 90% of the time and cost, but most importantly it can assist the government in planning and mitigation to save lives. To demonstrate the utility of the system, a BioTEMS Risk Assessment Map for COVID19 was developed for public health officials in southern Davao City, and is provided here within (Fig 1).

 

The BioTEMS Risk Assessment Map for COVID will provide the following capability to medical personnel and public health agencies :

1) Determine where and how many people to test,

2) Determine where to conduct environmental surveillance,

3) Maps at the scale of sampling and testing required by agencies; for example: local community, city, regional, national.

2) Optimal sample size and points for testing by clinical methods or surveys and sites for environmental testing

3) No specialized training will be needed to utilize the maps

4) The BioTEMS technology can be easily transitioned to local clinical and public health facilities to assist in surveillance at city, regional and national levels

Figure 1. Selected Optimal Sites for Surveillance Testing for COVID19 in Southern MAA Barangay, Davao City. (Red High Risk, Yellow-Moderate Risk). A minimum of 460 people (46 from each site) should be tested from the 8 high risk sample sites (red) and the two moderate risk sites (yellow).

1.2 Background

The risk to communities, government and military personnel, facilities and transport posed from infectious disease and biological weapons is significant.  The most recent example of the devastating impact of an infectious disease on public health is CoVID19. Other recent examples include avian influenza and Zika virus.  In addition to infectious diseases, biological weapons, including modified BW agents closely related to the parent agent at the genetic level, are generally identifiable using traditional diagnostics.  Advanced Biological Warfare Agents (ABW) and NTA overlap along a spectrum of characteristics and capabilities.  They include genetically modified organisms, material, nanotechnology, genocidal, bioregulators, delayed effect, and synthesized viruses that can be difficult to identify.  

Emerging infectious diseases and genetically modified organisms (GMO) may include the following characteristics: antibiotic resistance, increased aerosol stability, heightened pathogenesis, altered epitopes or sequences complicating current detection and diagnostics, nucleic recombination enhancing virulence and pathogenicity. Integrating surveillance, detection, diagnostic and modeling capabilities is critical for accurately assessing risk from pathogens and biological weapons.

 

In addition to current infectious disease and biological weapons models, such as EpiInfo and Joint Effect Model, risk assessment maps incorporating environmental factors are critical in protecting public health. The Bioagent Transport and Environmental Modeling System (BioTEMSÔ) was developed to meet concerns for infectious diseases and biological weapons, including those listed by the US National Research Council (NRC). These include: 1) accuracy requirements are higher for infectious diseases and bioagents than for chemical/physics models 2) low biological concentrations retaining infectious capability can occur over large geographic areas, and 3) after the initial aerosol dispersal - exposed organisms act as dispersive cells of infectious agents.  BioTEMS utilizes Geographic Information System and Artificial Intelligence that utilizes up to 150 variables to produce accurate output, visualized using off the shelf mapping software (Figures 2 and 3). 

Examples where BioTEMS Risk Assessment Maps (RAM’s) have been utilized include:

1) Defense Threat Reduction Agency: President Obama's Inauguration: Biological Weapons Defense
2) US Air force Academy: Plague
3) U.S. Navy military installation: Plague
4) U.S. Army and Dept of Environmental Health South Carolina: BioWeapons Surveillance and Defense
5) Aberdeen Proving Ground, Maryland, Avian Influenza, Vector-borne diseases and Bioweapons

7) Harris County Health Dept, Texas, Zika virus Surveillance

8) Afro European Medical Research Network, World Health Organization: Ebola Risk in Sierra Leonne

 

Figure 2. Recommended sites for Biogent sentinel traps and Zika virus surveillance (Yellow circles) using the Bioagent Transport and Environmental Transport System. Recommended integrated vector  management zones (Red Polygons).

 

Figure 3.   Risk assessment map of Ebola virus (EBOV) and free-living pathogenic amoeba in Sierra Leone (Red polygon- highest density of EBOV in environment, Orange polygon- moderate density of EBOV, Yellow polygon-lower density of EBOV; blue circles identify recommended sites for EBOV surveillance and environmental sampling.

 

2. THE TEAM

 

2.1 Principal Investigator: Professor Thomas Kollars

Dr. Kollars has over 30 years of international experience in epidemiology, public health, Chemical Biological Radiological and Nuclear weapons defense, university education and public health, where he has led and collaborated on chronic, infectious and vector-borne disease projects in over 50 countries with over 1,500 scientists and physicians. Tom has served as a department director and consultant in the Dept of Defense, academia and private firms with oversight over international health program management, infectious disease epidemiology, vector-borne diseases, molecular biology, immunology and GIS modeling and pharmaceutical/vaccine development. Tom is also fond of teaching and has taught K-12, undergraduate and graduate science, and public health courses in several countries in North America, Europe, Asia, Africa and Central America. Dr. Kollars retired after 23 years in the Army at the rank of LTC, having served in Combat Arms and Preventive Medicine. His last position held  in the military was Brigade Surgeon of the 415th Chemical Brigade, responsible for  oversight and coordination of medical operations for over 2,500 military and civilian personnel in the event of a release of weapons of mass destruction in North America.  He has also worked as a senior scientific consultant in the Biotechnology Engagement Program (BTEP) and Threat Agent Detection and Response (TADR) programs for HHS and DoD and led Red Cell teams and advised during national and international CBRN exercises.  Tom is a certified team leader and instructor in Consequence Management and Assessment (Defense Threat Reduction Agency) and a certified FEMA instructor in Pandemic Influenza and Emergency Management.  Tom has served as an instructor, senior consultant and has collaborated with several U.S. and International organizations including the Department of State, Department of Defense, NIH &CDC, the Smithsonian Institute, private businesses, the World Health Organization and Ministries of Health in Europe, Central America, SE Asia and Africa.  Tom is currently a Professor of Public Health at Liberty University and a Fellow of the American College of Epidemiology. He is honored to serve as the Epidemiologist Consultant, Vector Control Specialist, and Health Care and Emergency Operations Chaplain for the Afro European Medical and Research Network (AEMRN) and their North American Representative to the United Nations Economic and Social Council.  Dr. Kollars has over 80 peer reviewed publications and as an entrepreneur, several patents, and his inventions have been featured on international media, such as Scientific American, Discovery Channel, CNN’s Inside Africa and Trinity Broadcasting Network.

 

2.2 Staff:

The staff includes:

1) Epidemiologist

2) Program Manager for Pharmaceutical Testing

3) Professor of Emergency Management

4) Environmental Scientist

5) Programmer and GIS Technicians

6) Administrative staff

 

 

 

 

3.  FACILITIES AND EQUIPMENT

MedEnvVet Laboratories (MEVLABS):

Dr. Kollars and his late wife Peggy Kollars, founded MEVLABS in 2002 with the goal of producing public health products to “Make the World a Better Place.”  MEVLABS has provided consulting services for pharmaceutical research organizations, and received several grants and research and service contracts in public health, the most recent being DoD contracts on the development and testing of ecofriendly pesticides, chemical attractants, and products with visual and camouflage products and Zika Risk Assessment Maps of Zika virus for the Harris County Public Health Department, Texas. MEVLABS a Service Disabled Veteran Owned Small Business and is an EPA registered manufacturer of pesticides, with pest control operations in GA and SC.

 

MEVLABS is a  registered Biotechnology Research Company with the US Small Business Administration, and an EPA registered manufacturer and certified pest control company. MEVLABS facilities include a computer laboratory, environmental and molecular laboratory, insectary, manufacturing and production facility, and field station. Our offices, laboratory facilities and field station are located in Statesboro and Bulloch County Georgia. The laboratory and field facilities support a number of on-going research projects in pathogen and environmental assessment, pesticide trials, and mosquito population studies. Our manufacturing facility produces several components used in pesticides and devices used for vector control and community health in several countries and for sale in retail markets nationally and internationally. Through our collaborators we have access to a full complement of research, fabrication, and testing facilities.

 

 

4. Point of Contact:

Prof. Dr. Thomas M. Kollars

President and CSO

Email: tomkollars@mevlabs.com, tkollars@liberty.edu

Cell: 001 443 866 9438

Risk Assessment of COVID19

Risk Assessment of COVID19 using the BioAgent Transport and Environmental Modeling System (BioTEMS)

 

1. IDENTIFICATION AND SIGNIFICANCE OF THE PROBLEM

1.1 Executive Summary

The world faces an ever-growing threat from emerging pathogens and diseases, most recently Coronavirus disease 2019 (COVID19). In addition to clinical care, surveillance testing is a major factor in effective mitigation of infectious diseases. Surveillance includes identifying prevalence, incidence and identifying where COVID19 is found in populations in order to optimize testing and reduce the spread of COVID19. Emerging RT PCR kits and immunoassays are effective tools for identifying current and past COVID19 infections in clinical samples and can be used proactively to test sample populations. When testing kits are not available, interviews and surveys in communities can be used to ascertain potential exposure and infections in communities. Because it is not possible to test the entire population in large cities, the BioAgent Transport and Environmental Modeling System (BioTEMS) was developed to provide emergency response and public health personnel the information they need to enhance planning and target high risk areas in a cost and time-effective manner. Conducting surveillance by sampling at the community level optimizes available resources to combat the spread of disease. The BioTEMS COVID19 Risk Assessment Map (RAM) was developed for exactly this purpose.

 

Concerns for mitigation of COVID19 include; 1) Passively waiting for patients to be tested greatly underestimates the risk to the population, 2) Not testing for persistence and transmission SARS COV-2 in the environment in likely reservoirs underestimates the risk of re-emergence and genetic modification. The BioTEMS COVID19 RAM provides the public health administration an effective tool in answering these two questions rapidly and at greatly reduced cost.  For example, instead of testing 4,335 people in a community, 458 people can be tested at a 95% confidence level using the BioTEMS COVID19 RAM. Another very important factor for disease detection is sampling in the environment. The BioTEMS COVID19 RAM greatly reduces the area needed for accurate sampling. By accurately identifying Who and Where COVID19 sampling should be conducted, BioTEMS can save over 90% of the time and cost, but most importantly it can assist the government in planning and mitigation to save lives. To demonstrate the utility of the system, a BioTEMS Risk Assessment Map for COVID19 was developed for public health officials in southern Davao City, and is provided here within (Fig 1).

 

The BioTEMS Risk Assessment Map for COVID will provide the following capability to medical personnel and public health agencies :

1) Determine where and how many people to test,

2) Determine where to conduct environmental surveillance,

3) Maps at the scale of sampling and testing required by agencies; for example: local community, city, regional, national.

2) Optimal sample size and points for testing by clinical methods or surveys and sites for environmental testing

3) No specialized training will be needed to utilize the maps

4) The BioTEMS technology can be easily transitioned to local clinical and public health facilities to assist in surveillance at city, regional and national levels

Figure 1. Selected Optimal Sites for Surveillance Testing for COVID19 in Southern MAA Barangay, Davao City. (Red High Risk, Yellow-Moderate Risk). A minimum of 460 people (46 from each site) should be tested from the 8 high risk sample sites (red) and the two moderate risk sites (yellow).

1.2 Background

The risk to communities, government and military personnel, facilities and transport posed from infectious disease and biological weapons is significant.  The most recent example of the devastating impact of an infectious disease on public health is CoVID19. Other recent examples include avian influenza and Zika virus.  In addition to infectious diseases, biological weapons, including modified BW agents closely related to the parent agent at the genetic level, are generally identifiable using traditional diagnostics.  Advanced Biological Warfare Agents (ABW) and NTA overlap along a spectrum of characteristics and capabilities.  They include genetically modified organisms, material, nanotechnology, genocidal, bioregulators, delayed effect, and synthesized viruses that can be difficult to identify.  

Emerging infectious diseases and genetically modified organisms (GMO) may include the following characteristics: antibiotic resistance, increased aerosol stability, heightened pathogenesis, altered epitopes or sequences complicating current detection and diagnostics, nucleic recombination enhancing virulence and pathogenicity. Integrating surveillance, detection, diagnostic and modeling capabilities is critical for accurately assessing risk from pathogens and biological weapons.

 

In addition to current infectious disease and biological weapons models, such as EpiInfo and Joint Effect Model, risk assessment maps incorporating environmental factors are critical in protecting public health. The Bioagent Transport and Environmental Modeling System (BioTEMSÔ) was developed to meet concerns for infectious diseases and biological weapons, including those listed by the US National Research Council (NRC). These include: 1) accuracy requirements are higher for infectious diseases and bioagents than for chemical/physics models 2) low biological concentrations retaining infectious capability can occur over large geographic areas, and 3) after the initial aerosol dispersal - exposed organisms act as dispersive cells of infectious agents.  BioTEMS utilizes Geographic Information System and Artificial Intelligence that utilizes up to 150 variables to produce accurate output, visualized using off the shelf mapping software (Figures 2 and 3). 

Examples where BioTEMS Risk Assessment Maps (RAM’s) have been utilized include:

1) Defense Threat Reduction Agency: President Obama's Inauguration: Biological Weapons Defense
2) US Air force Academy: Plague
3) U.S. Navy military installation: Plague
4) U.S. Army and Dept of Environmental Health South Carolina: BioWeapons Surveillance and Defense
5) Aberdeen Proving Ground, Maryland, Avian Influenza, Vector-borne diseases and Bioweapons

7) Harris County Health Dept, Texas, Zika virus Surveillance

8) Afro European Medical Research Network, World Health Organization: Ebola Risk in Sierra Leonne

 

Figure 2. Recommended sites for Biogent sentinel traps and Zika virus surveillance (Yellow circles) using the Bioagent Transport and Environmental Transport System. Recommended integrated vector  management zones (Red Polygons).

 

Figure 3.   Risk assessment map of Ebola virus (EBOV) and free-living pathogenic amoeba in Sierra Leone (Red polygon- highest density of EBOV in environment, Orange polygon- moderate density of EBOV, Yellow polygon-lower density of EBOV; blue circles identify recommended sites for EBOV surveillance and environmental sampling.

 

2. THE TEAM

 

2.1 Principal Investigator: Professor Thomas Kollars

Dr. Kollars has over 30 years of international experience in epidemiology, public health, Chemical Biological Radiological and Nuclear weapons defense, university education and public health, where he has led and collaborated on chronic, infectious and vector-borne disease projects in over 50 countries with over 1,500 scientists and physicians. Tom has served as a department director and consultant in the Dept of Defense, academia and private firms with oversight over international health program management, infectious disease epidemiology, vector-borne diseases, molecular biology, immunology and GIS modeling and pharmaceutical/vaccine development. Tom is also fond of teaching and has taught K-12, undergraduate and graduate science, and public health courses in several countries in North America, Europe, Asia, Africa and Central America. Dr. Kollars retired after 23 years in the Army at the rank of LTC, having served in Combat Arms and Preventive Medicine. His last position held  in the military was Brigade Surgeon of the 415th Chemical Brigade, responsible for  oversight and coordination of medical operations for over 2,500 military and civilian personnel in the event of a release of weapons of mass destruction in North America.  He has also worked as a senior scientific consultant in the Biotechnology Engagement Program (BTEP) and Threat Agent Detection and Response (TADR) programs for HHS and DoD and led Red Cell teams and advised during national and international CBRN exercises.  Tom is a certified team leader and instructor in Consequence Management and Assessment (Defense Threat Reduction Agency) and a certified FEMA instructor in Pandemic Influenza and Emergency Management.  Tom has served as an instructor, senior consultant and has collaborated with several U.S. and International organizations including the Department of State, Department of Defense, NIH &CDC, the Smithsonian Institute, private businesses, the World Health Organization and Ministries of Health in Europe, Central America, SE Asia and Africa.  Tom is currently a Professor of Public Health at Liberty University and a Fellow of the American College of Epidemiology. He is honored to serve as the Epidemiologist Consultant, Vector Control Specialist, and Health Care and Emergency Operations Chaplain for the Afro European Medical and Research Network (AEMRN) and their North American Representative to the United Nations Economic and Social Council.  Dr. Kollars has over 80 peer reviewed publications and as an entrepreneur, several patents, and his inventions have been featured on international media, such as Scientific American, Discovery Channel, CNN’s Inside Africa and Trinity Broadcasting Network.

 

2.2 Staff:

The staff includes:

1) Epidemiologist

2) Program Manager for Pharmaceutical Testing

3) Professor of Emergency Management

4) Environmental Scientist

5) Programmer and GIS Technicians

6) Administrative staff

 

 

 

 

3.  FACILITIES AND EQUIPMENT

MedEnvVet Laboratories (MEVLABS):

Dr. Kollars and his late wife Peggy Kollars, founded MEVLABS in 2002 with the goal of producing public health products to “Make the World a Better Place.”  MEVLABS has provided consulting services for pharmaceutical research organizations, and received several grants and research and service contracts in public health, the most recent being DoD contracts on the development and testing of ecofriendly pesticides, chemical attractants, and products with visual and camouflage products and Zika Risk Assessment Maps of Zika virus for the Harris County Public Health Department, Texas. MEVLABS a Service Disabled Veteran Owned Small Business and is an EPA registered manufacturer of pesticides, with pest control operations in GA and SC.

 

MEVLABS is a  registered Biotechnology Research Company with the US Small Business Administration, and an EPA registered manufacturer and certified pest control company. MEVLABS facilities include a computer laboratory, environmental and molecular laboratory, insectary, manufacturing and production facility, and field station. Our offices, laboratory facilities and field station are located in Statesboro and Bulloch County Georgia. The laboratory and field facilities support a number of on-going research projects in pathogen and environmental assessment, pesticide trials, and mosquito population studies. Our manufacturing facility produces several components used in pesticides and devices used for vector control and community health in several countries and for sale in retail markets nationally and internationally. Through our collaborators we have access to a full complement of research, fabrication, and testing facilities.

 

 

4. Point of Contact:

Prof. Dr. Thomas M. Kollars

President and CSO

Email: tomkollars@mevlabs.com, tkollars@liberty.edu

Cell: 001 443 866 9438

Combat Prejudice Campaign

Dear everyone,

 

Having shared our experience on combating hate incidents and xenophobia at the Global Diaspora Virtual Exchange yesterday, we are initiating our global Combat Prejudice Campaign. The campaign aims to bring together as many supportive organisations as possible to send out a joint statement to the world that we are standing by all diaspora communities who are experiencing hatred at the moment. Not only we are sending out our message to protect each other, but also the love and care diaspora communities have given and received in their own regions.

 

As discussed at our conference, I proposed a two fold reassuring approach: reassurance by contributing and reassurance by protecting. It is working at our end and I hope the campaign can also further share this approach to reduce prejudice across the world.

 

Our invitation for support will go out soon. Meanwhile, please feel free to get in touch with us and thank you again for all your kindness and support to all races.

 

Please take care and keep safe.

 

Best wishes,

 

Peter

Campaigner

 

GERMIN initiatives in response to COVID-19

In response to COVID-19 our organization has taken the following initiatives: 

  1. Establishing the “Global Albanian Health Professionals COVID-19 Response Team” - a collaborative network of Albanians working in health care, public health and research and involved in the fight against COVID in all corners of the world.  

You can read more about it here: https://germin.org/global-albanian-health-professionals-covid-19-response-team/?fbclid=IwAR3VRaf1TLd6d-VnTZe__flvQf9HrCVGg0axPq7DQI8_sFAavBcVMzXvdaQ

  1. “Besa for Kosova” fundraising campaign in aid of the families in need where help packages containing food and basic hygiene products are being provided. All products are made in Kosova, thus supporting local manufacturers as well. 

You can read more about it here: https://germin.org/fillon-fushata-besa-per-kosoven-diaspora-ne-ndihme-te-atdheut-gjate-covid-19/

Fundraiser link: https://www.facebook.com/donate/2846525232062333/2856858781028978/

https://together.un.org MigApp https://sustainabledevelopment.un.org